biospecimen__admin__batch_number	327.54.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	E61E3B25-EA8B-4E4D-819B-518B6A8E11EC
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-A73F-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-A73F-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-A73F-01A
biospecimen__bio__biospecimen_barcode_bottom	0153880006
biospecimen__bio__day_of_creation	08
biospecimen__bio__day_of_shipment	25
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	08
biospecimen__bio__month_of_shipment	09
biospecimen__bio__pathology_report_file_name	TCGA-DD-A73F.2FCC867C-91AD-40B3-8046-FFB84BDD2EA7.pdf
biospecimen__bio__plate_column	2
biospecimen__bio__plate_id	A32J
biospecimen__bio__plate_row	C
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.40
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2013
biospecimen__bio__year_of_shipment	2013
biospecimen__shared__bcr_patient_barcode	TCGA-DD-A73F
biospecimen__shared__patient_id	A73F
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	E60CF0FA-1A02-4793-A411-8E2CE818AC12
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	4.6
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	0.5
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.6
clinical__chol_lihc_shared__creatinine_upper_limit	1.1
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.0
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	6
clinical__chol_lihc_shared__fetoprotein_outcome_value	283
clinical__chol_lihc_shared__fibrosis_ishak_score	0 - No Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	9.5
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	13.8
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__prothrombin_time_result_value	10.9
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Multiple
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	77
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-A73F-F66599
clinical__clin_shared__bcr_followup_uuid	83CD7205-69C2-4149-BC55-1EE28B6EA079
clinical__clin_shared__cancer_first_degree_relative	1
clinical__clin_shared__day_of_form_completion	18
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	1
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	YES
clinical__clin_shared__month_of_form_completion	3
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	243
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2015
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2010
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G1
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	3b2d478b-8898-453a-8954-f72a971bef10
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-A73F-01A-11R-A32J-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	78cce173-f4d0-463d-a6ba-8c272f082231
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.9
gdc__analytes__analyte_id	ae193276-c7a1-4faa-bcaf-c43d2d10e9ca
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	870c86e7-d6e1-4f9d-bb0b-bd1c66d6bcde
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:32:47.609868-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	6dd80b81-b4bd-5334-934c-dd3456d46d53
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__year_of_birth	1933
gdc__diagnoses__age_at_diagnosis	28234
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-28234.0
gdc__diagnoses__days_to_last_follow_up	1085.0
gdc__diagnoses__diagnosis_id	a568b5bf-83b4-58e7-a631-3d06b4b33e70
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	25.65437239738251
gdc__exposures__exposure_id	e5651308-05ee-50a6-a6ca-7ee4c1f35a44
gdc__exposures__height	164.0
gdc__exposures__weight	69.0
gdc__file_id	40a89801-479f-4dfe-a39b-a7ec4db12ff0
gdc__file_name	bcee2b22-b36a-4df1-b479-7bc569ad7fb6.mirbase21.mirnas.quantification.txt
gdc__file_size	50391
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	21ec96fbedcfe72496834b5f82f2148d
gdc__portions__is_ffpe	false
gdc__portions__portion_id	d5b21c86-0638-4fc8-be9b-7449c3a9991e
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	975
gdc__samples__initial_weight	250.0
gdc__samples__oct_embedded	false
gdc__samples__pathology_report_uuid	2FCC867C-91AD-40B3-8046-FFB84BDD2EA7
gdc__samples__sample_id	a15cf382-8456-4096-96a6-f211dea6ba78
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	12.0
gdc__slides__percent_monocyte_infiltration	1.0
gdc__slides__percent_necrosis	7.0
gdc__slides__percent_neutrophil_infiltration	1.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	20.0
gdc__slides__percent_tumor_cells	73.0
gdc__slides__percent_tumor_nuclei	80.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	e1c78f9c-cc2f-4546-a08e-2c8f65920e8f
gdc__submitter_id	mirna_swap_dr11_179_MirnaExpression04b37cb7-8850-49b3-849e-64fd65d2f255_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	fd52f9d1-0c50-5053-9a2a-7c3068930a65
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:07:55.169+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/3b2d478b-8898-453a-8954-f72a971bef10-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/3b2d478b-8898-453a-8954-f72a971bef10-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129762
manually_curated__local_md5	a8eb60ea14c89550c1ea6cd15f48e0b4
manually_curated__opengdc_download_date	2018-10-16T17:11:49.000308+02:00
manually_curated__opengdc_file_md5	0701a0272584bf876bf59840d87f884b
manually_curated__opengdc_file_size	50390
manually_curated__opengdc_id	3b2d478b-8898-453a-8954-f72a971bef10-meq
manually_curated__origin_file_size	129762
manually_curated__origin_last_modified_date	Tue Oct 16 17:53:00 CEST 2018
manually_curated__origin_md5	a8eb60ea14c89550c1ea6cd15f48e0b4
manually_curated__tissue_status	tumoral
